scholarly article | Q13442814 |
P356 | DOI | 10.1007/S00277-015-2446-4 |
P698 | PubMed publication ID | 26193851 |
P2093 | author name string | Hiroyasu Ogawa | |
Satoshi Yoshihara | |||
Masaya Okada | |||
Takayuki Inoue | |||
Hiroya Tamaki | |||
Jun Nakata | |||
Kyoko Taniguchi | |||
Katsuji Kaida | |||
Kazuhiro Ikegame | |||
Shinichi Ishii | |||
Toshihiro Soma | |||
Tatsuya Fujioka | |||
Ryoji Eguchi | |||
Ruri Kato | |||
P2860 | cites work | Sensitive detection of human cytomegalovirus peptide-specific cytotoxic T-lymphocyte responses by interferon-gamma-enzyme-linked immunospot assay and flow cytometry in healthy individuals and in patients after allogeneic stem cell transplantation | Q40734823 |
Infections after T-replete haploidentical transplantation and high-dose cyclophosphamide as graft-versus-host disease prophylaxis. | Q41484569 | ||
Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivation | Q42169566 | ||
Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection | Q43718520 | ||
Immune reconstitution to cytomegalovirus following partially matched-related donor transplantation: impact of in vivo T-cell depletion and granulocyte colony-stimulating factor-primed peripheral blood/bone marrow mixed grafts | Q44700785 | ||
Unmanipulated haploidentical bone marrow transplantation and posttransplantation cyclophosphamide for hematologic malignancies after myeloablative conditioning. | Q45745053 | ||
Cytomegalovirus immune reconstitution occurs in recipients of allogeneic hematopoietic cell transplants irrespective of detectable cytomegalovirus infection. | Q46025567 | ||
High-grade cytomegalovirus antigenemia after hematopoietic stem cell transplantation | Q46693835 | ||
Cytomegalovirus (CMV) infections and CMV-specific cellular immune reconstitution following reduced intensity conditioning allogeneic stem cell transplantation with Alemtuzumab | Q46693840 | ||
Patterns of cytomegalovirus reactivation are associated with distinct evolutive profiles of immune reconstitution after allogeneic hematopoietic stem cell transplantation | Q46744008 | ||
Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) bone marrow transplantation using only pharmacological GVHD prophylaxis | Q46962666 | ||
Dextramers: new generation of fluorescent MHC class I/peptide multimers for visualization of antigen-specific CD8+ T cells | Q46974705 | ||
Definitions of cytomegalovirus infection and disease in transplant recipients | Q28210268 | ||
Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation | Q32061754 | ||
Immune monitoring with iTAg MHC Tetramers for prediction of recurrent or persistent cytomegalovirus infection or disease in allogeneic hematopoietic stem cell transplant recipients: a prospective multicenter study | Q33589709 | ||
Protective effect of cytomegalovirus reactivation on relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients is influenced by conditioning regimen | Q33645271 | ||
Sequential anti-cytomegalovirus response monitoring may allow prediction of cytomegalovirus reactivation after allogeneic stem cell transplantation | Q34524941 | ||
Cytomegalovirus in hematopoietic stem cell transplant recipients | Q35922928 | ||
HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide | Q37078261 | ||
CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia | Q37098861 | ||
Cytomegalovirus infection/disease after hematopoietic stem cell transplantation | Q37736316 | ||
Cytomegalovirus diseases after hematopoietic stem cell transplantation: a mini-review. | Q38138287 | ||
P433 | issue | 10 | |
P921 | main subject | Cytomegalovirus | Q6946 |
P304 | page(s) | 1707-1715 | |
P577 | publication date | 2015-07-22 | |
P1433 | published in | Annals of Hematology | Q15766509 |
P1476 | title | Early detection of cytomegalovirus-specific cytotoxic T lymphocytes against cytomegalovirus antigenemia in human leukocyte antigen haploidentical hematopoietic stem cell transplantation | |
P478 | volume | 94 |